Episode 27: Preventing The Antimicrobial Resistance Health Crisis
Episode 27: Preventing The Antimicrobial Resistance Health Crisis
Vice President, Analyst, Responsible Investment
David joined BMO Global Asset Management in 2017. Prior to joining BMO, David held senior research positions at the governance research agencies PIRC and ISS, aft...
David joined BMO Global Asset Management in 2017. Prior to joining BMO, David held senior research positions at the governance research agencies PIRC and ISS, aft...
VIEW FULL PROFILE
November 18 marked the start of World Antimicrobial Awareness Week 2020, which aims to bring attention to the ever-evolving public health crisis of antimicrobial resistance (AMR) due to the overuse and misuse of antibiotics around the world.
Dame Sally Davies, UK Special Envoy on Antimicrobial Resistance, and James Anderson, Head of Corporate Government Affairs at GlaxoSmithKline, who leads the company’s advocacy on AMR, joins the podcast to discuss how antibiotic use in humans, livestock and plants is fueling AMR today. Plus, they provide an overview of engagement in this space to encourage responsible antibiotic use globally.
In this episode:
-
What is antimicrobial resistance and why is it such a pressing issue?
-
How the AMR Industry Alliance is combatting antibiotic overuse
-
Consumers and investors hold power to change antibiotic usage
-
The effects of inaction on antimicrobial resistance, and how we can change the trajectory
-
Overcoming commercial and scientific challenges in the development of new antimicrobial agents
Like what you hear? Subscribe today: Apple Podcasts, Google podcasts, Stitcher, Spotify
Visit bmo.com/sustainabilityleaders-podcast for more information about the podcast
Related Resources
